Published in Circ Res on February 01, 1988
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol (2009) 2.06
The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol (2011) 1.54
Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest (1989) 1.04
Hyponatraemia secondary to an inappropriately high release of antidiuretic hormone in cardiac tamponade. Br Heart J (1990) 0.97
The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Trans Am Clin Climatol Assoc (2004) 0.91
Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest (1989) 0.91
Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J (1993) 0.90
Block of stretch-activated atrial natriuretic peptide secretion by gadolinium in isolated rat atrium. J Physiol (1994) 0.88
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci (Lond) (2016) 0.87
Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart (1996) 0.84
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Gene (2015) 0.84
Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion. BMJ (1989) 0.83
Serum markers of systemic right ventricular function and exercise performance. Pediatr Cardiol (2008) 0.81
Relationship between status of plasma atrial natriuretic peptide and heart rate variability in human subjects. Heart Vessels (2012) 0.79
Natriuretic hormones in brain function. Front Endocrinol (Lausanne) (2014) 0.79
Vasopeptidase inhibitors: will they have a role in clinical practice? Br J Clin Pharmacol (2004) 0.79
Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol (2006) 0.78
Left atrial minimum volume is more strongly associated with N-terminal pro-B-type natriuretic peptide than the left atrial maximum volume in a community-based sample. Int J Cardiovasc Imaging (2015) 0.78
Urinary cGMP concentrations in severe primary pulmonary hypertension. Thorax (1998) 0.77
Circulating plasma concentrations of atrial natriuretic peptide and catecholamines in response to maximal exercise in normal and asthmatic subjects. Thorax (1991) 0.77
Cardiac atria are the primary source of ANP release in hypoxia-adapted rats. Life Sci (2010) 0.77
Editorial: Natriuretic Hormones. Front Endocrinol (Lausanne) (2015) 0.76
Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest (1991) 0.76
Neuroendocrine changes in chronic cardiac failure. Basic Res Cardiol (1996) 0.76
Novel drug targets in clinical development for heart failure. Eur J Clin Pharmacol (2014) 0.76
Atrial Natriuretic Peptide and Acute Changes in Central Blood Volume by Hyperthermia in Healthy Humans. Open Neuroendocrinol J (2012) 0.75
Increasing atrial pressure during cardiac tamponade does not elevate plasma levels of the peptide ANP in conscious dogs. J Physiol (1990) 0.75
Modulation by atrial natriuretic factor of receptor-mediated cyclic AMP-dependent responses in canine pulmonary artery during heart failure. Br J Pharmacol (1996) 0.75
Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris. Br J Clin Pharmacol (1993) 0.75
Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study. J Am Heart Assoc (2016) 0.75
Effects of immobilizations stress with or without water immersion on the expression of atrial natriuretic peptide in the hearts of two rat strains. Am J Transl Res (2016) 0.75
Contribution of the ventricles and the atrial appendages to the elevation of plasma atrial natriuretic factor (ANF) during pacing-induced heart failure in conscious dogs. Basic Res Cardiol (1997) 0.75
Optical control of a receptor-linked guanylyl cyclase using a photoswitchable peptidic hormone. Chem Sci (2017) 0.75
Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation. Heart Vessels (2016) 0.75
Serum atrial natriuretic peptide (ANP) as an objective indicator for the diagnosis of neurogenic shock: animal experiment and human case report. Int J Legal Med (2016) 0.75
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (1986) 3.37
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet (1993) 3.34
Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg (1992) 2.61
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37
Risk factors for early adolescent drug use in four ethnic and racial groups. Am J Public Health (1993) 2.28
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med (1991) 2.22
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Atrial natriuretic peptide and blood pressure in a population-based sample. Mayo Clin Proc (1995) 1.98
Occipital nerve stimulation for chronic headache--long-term safety and efficacy. Cephalalgia (2007) 1.91
Surgical evaluation and management of lumbar synovial cysts: the Mayo Clinic experience. J Neurosurg (2000) 1.89
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Natriuretic peptide system in human heart failure. Circulation (1993) 1.79
Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol (1984) 1.71
Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc (1992) 1.70
Acculturation and delinquent behavior among Cuban American adolescents: toward an empirical model. Am J Community Psychol (1993) 1.70
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart (2009) 1.69
Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis (1999) 1.67
Patterns of drug use among Cuban-American, African-American, and white non-Hispanic boys. Am J Public Health (1993) 1.63
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation (1990) 1.57
Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest (1989) 1.57
Endothelin in human congestive heart failure. Circulation (1994) 1.56
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation (1995) 1.55
Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol (1990) 1.55
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc (1998) 1.53
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest (1988) 1.53
Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol (1992) 1.50
Illness representations and matching labels with symptoms. Health Psychol (1989) 1.46
Which is more important to high school students: preventing pregnancy or preventing AIDS? Fam Plann Perspect (1994) 1.46
Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am J Physiol Heart Circ Physiol (2001) 1.44
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation. J Am Coll Cardiol (1990) 1.41
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Hashimoto's thyroiditis. An uncommon cause of painful thyroid unresponsive to corticosteroid therapy. Ann Intern Med (1986) 1.33
Race, socioeconomic status, and psychological distress: an examination of differential vulnerability. J Health Soc Behav (1989) 1.33
The role of religion in predicting adolescent alcohol use and problem drinking. J Stud Alcohol (2001) 1.32
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol (1998) 1.32
Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol (1980) 1.31
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc (2001) 1.29
Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol (2000) 1.28
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol (1992) 1.27
Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol (1993) 1.26
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. Circ Res (1999) 1.24
Failing energetics in failing hearts. Curr Cardiol Rep (2000) 1.24
Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol (1992) 1.23
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 1.23
Adrenomedullin: potential in physiology and pathophysiology. Life Sci (2000) 1.22
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians (1999) 1.20
C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol (1993) 1.19
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation (1995) 1.18
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int (1996) 1.15
The link between the use of crack cocaine and the sexually transmitted diseases of a clinic population. A comparison of adolescents with adults. Sex Transm Dis (1997) 1.13
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
Perceived versus actual condom skills among clients at sexually transmitted disease clinics. Public Health Rep (1994) 1.09
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J (1999) 1.09
The second move: health and geographic mobility. J Gerontol (1991) 1.08
Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail (2000) 1.07
Cerebral blood flow and metabolism in severely head-injured children. Part 1: Relationship with GCS score, outcome, ICP, and PVI. J Neurosurg (1989) 1.07
Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep (2000) 1.06
Renal actions of synthetic dendroaspis natriuretic peptide. Kidney Int (1999) 1.05
Intact and altered endothelium in regulation of vasomotion. Circulation (1992) 1.05
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab (2012) 1.05
Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Hypertension (2001) 1.05
Use of the exercise treadmill to measure baseline functional status and surgical outcome in patients with severe lumbar spinal stenosis. Spine (Phila Pa 1976) (1998) 1.04
Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol (1992) 1.04
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation (1993) 1.03
C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol (1998) 1.03
Risks for renal dysfunction with cardiac angiography. Ann Intern Med (1986) 1.03
Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol (2000) 1.02
Gender and ethnic differences in the prevalence of alcohol, cigarette, and illicit drug use over time in a cohort of young Hispanic adolescents in south Florida. Women Health (1996) 1.02
A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest (1995) 1.02
Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol (1997) 1.02
Measurement of exercise tolerance on the treadmill in patients with symptomatic lumbar spinal stenosis: a useful indicator of functional status and surgical outcome. J Neurosurg (1995) 1.01
Adolescents' perceived ability to say "no" to unwanted sex. J Adolesc Res (1995) 1.01
Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension. Circ Res (1986) 1.01
Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc (1991) 1.01
Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol (1995) 0.99
Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol (1989) 0.97
Endothelin has biological actions at pathophysiological concentrations. Circulation (1991) 0.97
Segmental analysis of sodium reabsorption during renal vein constriction. Am J Physiol (1982) 0.97
Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest (1993) 0.97
ANP inhibits Na(+)-H+ antiport in proximal tubular brush border membrane: role of dopamine. Kidney Int (1990) 0.97
The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure. Mayo Clin Proc (1986) 0.96
Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am J Physiol Heart Circ Physiol (2000) 0.96